These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7029926)

  • 21. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inherited antithrombin deficiency and end stage renal disease.
    Hara T; Naito K
    Med Sci Monit; 2005 Nov; 11(11):RA346-54. PubMed ID: 16258410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired antithrombin III deficiency in patients with glomerular proteinuria.
    Thaler E; Balzar E; Kopsa H; Pinggera WF
    Haemostasis; 1978; 7(5):257-72. PubMed ID: 689489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombin III deficiency in a Romanian family. Pathogenic role of concomitantly increased plasma level of clotting factors VII and X.
    Cucuianu M; Comes L; Roman S; Boeru A
    Med Interne; 1984; 22(1):13-7. PubMed ID: 6710043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial thromboembolic disease associated with antithrombin III deficiency (author's transl)].
    Bentata-Pessayre M; Aurousseau MH; Josso F; Delzant G
    Ann Med Interne (Paris); 1980; 131(6):378-82. PubMed ID: 7469244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of antithrombin III in clinical liver transplantations].
    Lohse W; Winkler H; Wolff H
    Zentralbl Chir; 1985; 110(13):803-10. PubMed ID: 3898652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
    Ambruso DR; Jacobson LJ; Hathaway WE
    Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [At II in liver diseases. Comparison between immunological determination and that with chromogenic substrate].
    Carmignoto F; Schivo P; Zotti S; Ceriotti G
    Arch Sci Med (Torino); 1980; 137(3):467-70. PubMed ID: 6786256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA; Moia M; Rivolta E; Ponticelli C; Mannucci PM
    Thromb Haemost; 1999 Sep; 82(3):1020-3. PubMed ID: 10494757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the clinical significance of acquired antithrombin deficiency.
    Sørum Y; Handeland GF; Abildgaard U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):797-805. PubMed ID: 6083956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heparin cofactor II (HCII) activity and antigen assay and their significance in thrombotic diseases].
    Dai CW; Zhang GS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):452-4. PubMed ID: 14575585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protein S deficiency and thrombophilia: presentation of a clinical case and review of the literature].
    Iannello S; Prestipino M; Volpicelli G; Campione R; Belfiore F
    Ann Ital Med Int; 1994; 9(3):153-9. PubMed ID: 7946892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombin III metabolism in two colitis patients with acquired antithrombin III deficiency.
    Knot EA; ten Cate JW; Bruin T; Iburg AH; Tytgat GN
    Gastroenterology; 1985 Aug; 89(2):421-5. PubMed ID: 4007429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemostatic abnormalities in patients with liver disease associated with viral hepatitis.
    Pramoolsinsap C; Busagorn N; Kurathong S
    J Med Assoc Thai; 1996 Nov; 79(11):681-8. PubMed ID: 8997005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary and acquired antithrombin deficiency.
    Vinazzer H
    Semin Thromb Hemost; 1999; 25(3):257-63. PubMed ID: 10443957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.